Leerink Partnrs Has Pessimistic View of Danaher Q1 Earnings

Danaher Co. (NYSE:DHR) – Leerink Partnrs lowered their Q1 2025 EPS estimates for shares of Danaher in a report issued on Wednesday, January 29th. Leerink Partnrs analyst P. Souda now anticipates that the conglomerate will post earnings per share of $1.63 for the quarter, down from their previous forecast of $2.02. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. Leerink Partnrs also issued estimates for Danaher’s Q4 2025 earnings at $2.43 EPS, FY2025 earnings at $7.65 EPS, Q1 2026 earnings at $1.93 EPS, Q2 2026 earnings at $1.96 EPS, Q3 2026 earnings at $2.05 EPS, Q4 2026 earnings at $2.66 EPS and FY2026 earnings at $8.60 EPS.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same quarter last year, the company earned $2.09 EPS.

Several other analysts have also recently commented on the company. StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Stifel Nicolaus boosted their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a report on Wednesday, October 23rd. Bank of America raised shares of Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target on the stock in a research note on Friday, December 13th. Raymond James lowered their price objective on shares of Danaher from $300.00 to $275.00 and set an “outperform” rating for the company in a research note on Tuesday, January 21st. Finally, Barclays cut their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and an average target price of $278.00.

Danaher Price Performance

Shares of NYSE:DHR opened at $222.56 on Monday. The company has a market cap of $160.75 billion, a P/E ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83. The business has a fifty day simple moving average of $235.40 and a 200-day simple moving average of $253.08. Danaher has a 52 week low of $221.34 and a 52 week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.49%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s payout ratio is 20.45%.

Insider Buying and Selling

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the firm’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This trade represents a 21.98 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 11.10% of the company’s stock.

Hedge Funds Weigh In On Danaher

Several large investors have recently modified their holdings of DHR. AMF Tjanstepension AB bought a new position in Danaher during the 3rd quarter worth approximately $5,923,000. Czech National Bank raised its position in shares of Danaher by 4.2% during the 3rd quarter. Czech National Bank now owns 130,939 shares of the conglomerate’s stock valued at $36,404,000 after acquiring an additional 5,320 shares in the last quarter. GAMMA Investing LLC lifted its stake in Danaher by 33.5% during the third quarter. GAMMA Investing LLC now owns 4,480 shares of the conglomerate’s stock worth $1,246,000 after purchasing an additional 1,125 shares during the last quarter. WealthBridge Capital Management LLC boosted its holdings in Danaher by 51.8% in the third quarter. WealthBridge Capital Management LLC now owns 1,465 shares of the conglomerate’s stock worth $407,000 after purchasing an additional 500 shares during the period. Finally, Diversified Trust Co increased its stake in Danaher by 29.6% during the third quarter. Diversified Trust Co now owns 5,649 shares of the conglomerate’s stock valued at $1,571,000 after purchasing an additional 1,289 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.